Feedback / Questions
MTX-463 - Eli Lilly
MTX-474 - Mediar Therap
https://www.prnewswire.com/news-releases/mediar-therapeutics-doses-first-patient-in-phase-2-wisper-trial-of-mtx-463-for-idiopathic-pulmonary-fibrosis-302473778.html
Jun 5, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next